Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Translational Science

Discovery & Development Clinical Trials

We are the Resensitizers

| Angus Stewart | 8 min read

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?

Discovery & Development Drug Discovery

One Small Step for Man, One Giant Leap For Science

| Stephanie Sutton | 8 min read

We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.

Discovery & Development Drug Discovery

The Final Frontier for Regenerative Medicine

| Stephanie Sutton

What will drug development look like aboard a new commercial space station?

Discovery & Development Drug Discovery

Nurse Sharks and VNARs

How work on sharks could provide a highly effective weapon against new COVID variants

Discovery & Development Drug Discovery

The Next Frontier in HIV Prevention

| Maryam Mahdi

Exploring the potential of vaccines for treatment equity.

Discovery & Development Drug Discovery

The Tale of Two TULIPs

| Angus Stewart

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Discovery & Development Vaccines

Backwards Vax Moves Forward

| Angus Stewart

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

Discovery & Development Drug Discovery

Completing the Cell Therapy Revolution

| James Strachan

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Discovery & Development Drug Discovery

Unleashing Cellular Potential

| James Strachan

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

Business & Regulation Standards & Regulation

Watching the Future

| James Strachan

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register